Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$1.71 - $3.71 $702 - $1,524
-411 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$6.08 - $8.92 $91 - $133
-15 Reduced 3.52%
411 $3,000
Q2 2021

Jul 23, 2021

BUY
$6.65 - $9.95 $99 - $149
15 Added 3.65%
426 $4,000
Q1 2021

May 10, 2021

BUY
$8.67 - $21.7 $34 - $86
4 Added 0.98%
411 $4,000
Q4 2020

Feb 24, 2021

BUY
$7.19 - $17.05 $2,796 - $6,632
389 Added 2161.11%
407 $5,000
Q4 2020

Feb 12, 2021

SELL
$7.19 - $17.05 $2,825 - $6,700
-393 Reduced 95.62%
18 $5,000
Q3 2020

Nov 10, 2020

BUY
$6.27 - $15.8 $2,576 - $6,493
411 New
411 $3,000

About ORGANOVO HOLDINGS, INC.


  • Ticker ONVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,712,020
  • Market Cap $3.75M
  • Description
  • Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...
More about ONVO
Track This Portfolio

Track Bank Julius Baer & Co. Ltd, Zurich Portfolio

Follow Bank Julius Baer & Co. Ltd, Zurich and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.